Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://ncbi.nlm.nih.gov/pubmed/26620566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1949-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky